Science

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün/X

Feb 8, 2025, 19:19

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Veronica Hernström, et al. on LinkedIn:

“Largest AI Mammography Trial: Game-Changer!

105,934 women screened.
29% more cancers detected.
44% reduction in screen-reading workload.
No rise in false positives.

AI is reshaping breast cancer screening!”

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

Authors: Veronica Hernström, et al.

Yüksel Ürün: Largest AI Mammography Trial, Game-Changer

AI Mammography Trial Ankara University School of Medicine artificial intelligence Breast Cancer cancer fight against cancer Global fight against cancer Mammography Trial MASAI MedOnc OncoDaily Oncology Veronica Hernström Yüksel Ürün

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology